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ViabilityAbstract Nasopharyngeal carcinoma (NPC) at present is considered to be one of the fatal diseases
detected commonly in the people belonging to Southeast Asia and southern China. According to
the WHO reports among the detected cases of NPC worldwide, 80% are from China. The present
study investigates the effect of tanshinone IIA on the migration and invasion potential of HNE-
1NPC cells and studied the detailed mechanism involved. Effect of the tanshinone IIA on viability
of the HNE-1NPC cells was analyzed by MTS assay. Cell matrigel invasion and wound-healing
motility assays, respectively were used for the analysis of invasion and migration potential of
HNE-1 cells. Tanshinone IIA inhibited the viability of HNE-1cells in a dose dependent manner.
Migration and invasion potential of the tanshinone IIA treated cells was reduced significantly
(P< 0.05) compared to the control cells after 48 h. Analysis of the proteins involved in migration
and invasion revealed a significant decrease in the expression of matrix metalloproteinase (MMP)-2
and MMP-9 on treatment with tanshinone IIA. It also inhibited the p65 and p50 expression in the
nuclear fractions of HNE-1 cells after 48 h. Thus, tanshinone IIA inhibits migration and invasion
potential of the HNE-1NPC cells through reduction in the expression of matrix metalloproteinases.
Therefore, tanshinone IIA can be used for the treatment of NPC.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nasopharyngeal carcinoma (NPC) at present is considered to
be one of the fatal diseases detected commonly in the peoplebelonging to Southeast Asia and southern China (Chang and
Adami, 2006). According to the WHO reports among the
detected cases of NPC worldwide, 80% are from China. Most
of the NPC cases are difficult to be differentiated from the
squamous cancer (Guigay, 2008). This malignant tumor can
be treated at the early stage by radiotherapy and its progres-
sion delayed by chemotherapeutic agents (Kalaiselvi et al.,
2016; Serasanambati and Chilakapati, 2016). It is reported that
the 5-year survival rate of patients with NPC is very low and
the incidence of relapses is high (Vlantis et al., 2007). Studies
have demonstrated that NPC metastasizes to the lymphatic
nodes present in the neck in around 80% of the cases (Chuaurnal of
2 M. Zhou et al.et al., 2001). NPC metastasis is a big hurdle for the successful
inhibition of cancer by various chemotherapeutic agents. Fur-
thermore, NPC penetrates to the distant tissues like lung, liver
and bones (Cheng et al., 1998). Carcinoma metastasis involves
breakdown of the extracellular matrix (ECM) which is accom-
panied by cell invasion and migration to other tissues (Raghu
et al., 2010; Chen et al., 2013). Breakdown of the ECM and
therefore enhancement in the migration and invasion of poten-
tial of carcinoma cells is catalyzed by enzymes known as
matrix metallo-proteinases (MMPs) (Bjorklund and
Koivunen, 2005; Yang et al., 2005).
Metabolites derived from the medicinal plants play an
important role in protecting the human body from various
diseases (Neelamkavil and Thoppil, 2016; Noorudheen and
Chandrasekharan, 2016; Santhosh et al., 2016; Valsan and
Raphael, 2016). Tanshinone IIA is isolated from the plant
Radix Salvia miltiorrhiza and comprises its active constituent
(Che et al., 2004; Zhou et al., 2005). Analysis of the biolog-
ical activity of tanshinone IIA revealed various activities
including, anti-inflammatory activities (Jang et al., 2006; Li
et al., 2007) and antioxidant properties (Lin et al., 2006;
Wang et al., 2003). It has been demonstrated that tanshinone
IIA treatment inhibits carcinoma cell growth through sup-
pression of ErbB-2 and promotion of TNF-a expression
(Su and Lin, 2008a). In breast carcinoma cells exposure to
tanshinone IIA promotes ratio of Bax to Bcl-xL expression
(Su and Lin, 2008b). While as in human non-small cell lung
cancer cells it induces expression of reactive oxygen species
and decreases the mitochondrial membrane potential (Chiu
and Su, 2010). In case of lung and breast cancer cells tanshi-
none IIA treatment inhibits growth through induction of ER
stress (Cheng and Su, 2010; Yan et al., 2012). The present
study demonstrates the effect of tanshinone IIA on the inva-
sive and migration potential of NPC cells. Tanshinone IIA
treatment significantly inhibited the migration and invasion
potential of the NPC cells.2. Materials and methods
2.1. Reagents and chemicals
Tanshinone II and dimethyl sulphoxide were purchased
from Sigma–Aldrich (St. Louis, MO, USA). Other common
solvents, reagents and chemicals used were of analytical or
high-performance liquid chromatography (HPLC) grade
from Sigma–Aldrich or Merck (Darmstadt, Germany). All
the antibodies used in the study were mouse monoclonal
supplied by Cell Signaling Technologies (Danvers, MA,
USA).
2.2. Cell culture
The human HNE-1cell line was purchased from the Food
Industry Research and Development Institute (Hsinchu,
Taiwan). The cells were cultured on 75 cm2 tissue culture
flasks with RPMI1640 medium (Gibco BRL). The cell medium
with 2 mM L-glutamine was adjusted to contain 10% fetal
bovine serum (Gibco BRL), and 1% penicillin–streptomycin
(100 U/ml penicillin and 100 lg/ml streptomycin) and grown
at 37 C under a humidified 5% CO2 atmosphere.Please cite this article in press as: Zhou, M. et al., Tanshinone IIA suppress the prolif
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HNE-1cells were distributed at a density of 2  105 cells per
well in 100 ll RPMI with 10% FBS in to the wells of a
96-well plate. The cells were incubated with 10, 20, 30, 40
and 50 lM concentrations of tanshinone II for 48 h. The con-
trol cell cultures were treated with medium alone without tan-
shinone II. For the determination of cell viability 30 ll Cell
Titer 96 AQueous One Solution Reagent (MTS; Promega
Corporation, Madison, WI, USA) was added to each well of
the plate. The plates were incubated for 45 min in an incubator
at 37 C with humid atmosphere of 5% CO2. For each well
absorbance was recorded by ELISA plate reader (Bio-Tek
Instruments, Inc., Winooski, VT, USA) at a wavelength of
475 nm. The experiment was reported three times for each well
and compared with the control cultures.
2.4. Cell matrigel invasion assays
Invasion of the HNE-1NPC cells through a matrigel basement
membrane (Sigma–Aldrich, Carlsbad, CA, USA) was ana-
lyzed. Briefly, the filters of polycarbonate were coated on the
under surface with fibronectin and were placed in 24-well
Transwell cell culture chambers (Chemicon, Temecula, CA,
USA). The upper surface of the filters was coated with Matri-
gel and the control wells left uncoated. Dry filters were washed
with PBS, rehydrated and then 2  106 NPC cells in RPMI-
1640 medium were suspended in the chambers. After incuba-
tion of the cells with tanshinone II for 48 h, the cells that
invaded the lower chamber of the filter were stained with cal-
cein. Quantification of the cells was performed at 489 and
525 nm excitation and emission wavelengths, respectively.
2.5. Migration assay
Migration potential of the HNE-1 cells was analyzed by using
wound-healing motility assay. The cells were distributed at a
density of 3  105 cells into the 6-well culture plates with tan-
shinone II or without as control and incubated for 48 h. The
cells were then scratched using a plastic cell scraper and the cel-
lular monolayer was rinsed in PBS for the removal of detached
cells. The cells adhered were incubated for 1 h more at 37 C in
a humidified atmosphere containing 5% CO2 and 95% air.
Decrease in the scraped cellular zone width compared to the
control determined the cell migration. The Olympus-CX31
microscope (Olympus Corp.) was used for the measurement
of migratory distance covered by the cells.
2.6. Zymography
In order to determine the activity of MMP-2 and MMP-9 NPC
cells were incubated with tanshinone II for 48 h. Following
incubation, the cell lysates were collected to determine the
expression of the proteins. The protein samples (30 ll) were
isolated by electrophoresis on 10% SDS–PAGE gel. The gels
were treated for 45 min at room temperature with 5% Triton
X-100 solution (Sigma–Aldrich) followed by incubation for
12 h with reaction buffer (10 mM CaCl2, 40 mM Tris–HCl
and 0.01% NaN3, pH 8.0). Staining and de-staining of the gels
was performed using 0.1% Coomassie brilliant blue R-250eration of HNE-1 nasopharyngeal carcinoma an in vitro study. Saudi Journal of
Figure 1 Inhibition of HNE-1NPC cell viability by tanshinone
IIA in dose dependent manner. The cells were incubated for 48 h
with 10, 20, 30, 40 and 50 lM doses of tanshinone IIA followed by
analysis using MTS assay. The experiments were performed in
triplicates and the data presented are the mean ± standard
deviation. Where, *P< 0.04 and **P< 0.02, data were compared
to the control group at 48 h.
Figure 2 Tanshinone II inhibits the migration potential of the
HNE-1NPC cells. The cells were incubated in media containing
various concentrations of tanshinone II or in media alone as
control. Following incubation the cells were analyzed by matrigel
invasion assay for migration potential. The data presented are the
mean ± standard deviation of the experiments performed in
triplicates. Where *P< 0.05 and **P< 0.01, data were compared
with the control group.
Role of Tanshinone IIA in cancer cells 3(Sigma–Aldrich) and mixture of 30% methanol and 10%
acetic acid, respectively. The image analysis system (Quantity
One v4.62; Bio-Rad Laboratories) was used to record the band
intensities.
2.7. Western blot analysis
The HNE-1 cells after incubation with tanshinone II were col-
lected and lysed in RIPA buffer (50 mM Tris-base, 1.0 mM
EDTA, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1%
sodium deoxycholate, 1 mM PMSF). The extracted proteins
were quantified using DC protein assay Kit (Bio-Rad). The
protein samples were isolated on 10% SDS–PAGE and then
transferred to polyvinylidenedifluoride (PVDF) membranes
(Amersham Biosciences). The non-specific sites on the mem-
branes were blocked by incubation with PBS supplementedPlease cite this article in press as: Zhou, M. et al., Tanshinone IIA suppress the prolif
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the proteins was performed by incubation with of the mem-
branes with polyclonal antibodies against MMP-2, MMP-9,
p50, p65 and b-actin (diluted 1:500, Abcam, UK). Following
overnight incubation, the membranes were incubated for 1 h
with secondary antibodies conjugated to horseradish peroxi-
dase. The enhanced chemiluminescence reagents (Amersham
Pharmacia Biotech, Piscataway, USA) were used for the visu-
alization of the proteins.
2.8. Statistical analysis
The data expressed are the means ± SD. Student’s t-test was
used for the comparing the two groups. One-way ANOVA
analysis was also used to analyze the data obtained. Relevance
analysis of ordinal data was performed by cross v2 test. A sta-
tistically significant difference was defined as p< 0.05.
3. Results
3.1. Inhibition of HNE-1NPC cell proliferation by tanshinone
IIA
Effect of tanshinone IIA on the viability of HNE-1 cells was
analyzed by MTS assay. The results revealed a dose dependent
decrease in the cell viability on treatment with tanshinone IIA
for 48 h. Viability of HNE-1 cells was decreased by 9.37, 23.64,
38.65, 52.52 and 73.55%, respectively on treatment with 10, 20,
30 and 50 lM concentration of tanshinone IIA after 48 h
(Fig. 1).3.2. Inhibition of NPC cell migration by tanshinone II
The effect of tanshinone II on the migration potential of HNE-
1 cells was also analyzed. The results showed reduction in the
migration potential of HNE-1 cells in a concentration depen-
dent manner after 48 h. Tanshinone II treatment at the doses
of 1, 2, 4, 6 and 8 lM concentration reduced the migration
potential by 2.5, 9.12, 18.76, 39.45 and 61.23%, respectively
after 48 h (Fig. 2).
3.3. Inhibition of HNE-1NPC cell invasion by tanshinone II
Analysis of the invasive behavior revealed a significant
decrease on treatment with tanshinone II for 48 h in HNE-1
cells (Fig. 3). The invasive potential at 1, 2, 4, 6 and 8 lM con-
centration of tanshinone II was decreased by 4.2, 7.43, 21.54,
42.31 and 72.62%, respectively after 48 h.
3.4. Inhibition of MMP-2 and MMP-9 protein expression by
tanshinone II
We also analyzed the effect of tanshinone II on the expression
level of MMP-2 and MMP-9 protein and their corresponding
activity. The results revealed that tanshinone II treatment
caused a comparatively significant decrease in the expression
of MMP-2 and MMP-9 after 48 h in HNE-1cells (Fig. 4).
The reduction in expression was also evident by a significant
decrease in the MMP-2 and MMP-9 activity.eration of HNE-1 nasopharyngeal carcinoma an in vitro study. Saudi Journal of
Figure 3 Tanshinone II inhibits the invasion potential of the
HNE-1 cells. The cells were incubated in media containing
tanshinone II or in media alone as control. Following incubation
the cells were analyzed by wound-healing assay for invasion
potential. The data presented are the mean ± standard deviation
of the experiments performed in triplicates. Where *P< 0.05 and
**P< 0.01, data were compared with the control group.
4 M. Zhou et al.3.5. Effect of tanshinone IIon nuclear translocation of p50 and
p65
Analysis of the level of NF-jB in the tanshinone II treated
HNE-1cells revealed a significant decrease in p65 and p50
expression after 48 h (Fig. 5). The reduction in the expressionFigure 4 Inhibition of matrix metalloproteinase (MMP)-2 and MM
treated with tanshinone IIA at different doses for 48 h followed by
expression. Inhibition of MMP-2 and MMP-9 activity by tanshinone I
of the experiments performed in triplicates. Where *P< 0.03 and **P
Please cite this article in press as: Zhou, M. et al., Tanshinone IIA suppress the prolif
Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.11.004of NF-jB was found to be similar in the cells treated with both
henenalin (NF-jB inhibitor) and tanshinone II.
4. Discussion
Nasopharyngeal carcinoma is one of the most commonly
detected malignant tumor that can be treated at the early stage
by radiotherapy and its progression delayedby chemotherapeutic
agents.However,NPCmetastasis is a big hurdle for the successful
inhibition of cancer by various chemotherapeutic agents. There-
fore, inhibition of the NPC metastasis by any method can play
a promising role in the treatment of NPC. In the present study
effect of tanshinone II on the inhibitionofmigration and invasion
potential of NPC cells and the underlying mechanism was inves-
tigated. Treatment of the NPC cells with tanshinone II signifi-
cantly reduced the migration and invasion potential of NPC
cells. Carcinoma cell metastasis to lymph and blood vessels is
facilitated by the breakdown of ECM (Chen et al., 2013). The
results from the present study revealed that treatment of the
NPC cells with tanshinone II significantly reduced the migration
potential. Tanshinone II induced reduction in the migration and
invasion potential of NPC cells was clearly evident from the
wound healing and the Boyden chamber assays.
It is reported that breakdown of the ECM to mediate carci-
noma cell metastasis is regulated by MMP-2 and MMP-9 (Yan
et al., 2012; Gialeli et al., 2011). Results from the present study
revealed that tanshinone II treatment caused a significant
decrease in the MMP-2 and MMP-9 expression in NPC-039
cells after 48 h. Tanshinone II treatment also resulted in
decrease in the MMP-2 and MMP-9 activity in NPC cells after
48 h. Studies have demonstrated that expression of MMP-2
and MMP-9 is enhanced in the carcinoma cells by NF-jB
(Yeh et al., 2012; Yu et al., 2009, 2011). Results from the pre-
sent study demonstrated that tanshinone II treatment in NPC
cells enhanced the p65 and p50 expression. Thus it appears that
tanshinone II inhibits migration and invasion potential of the
NPC cells through reduction in the NF-jB expression.P-9 expression by tanshinone IIA in HNE-1 cells. The cells were
western blotting analysis to examine the MMP-2 and MMP-9
IA in NPC cells. The presented are the mean ± standard deviation
< 0.02, data were compared with the control group.
eration of HNE-1 nasopharyngeal carcinoma an in vitro study. Saudi Journal of
Figure 5 Effect of tanshinone IIA on the nuclear factor (NF)-jB-related protein expression in HNE-1 cells. (A) Inhibition of the p50 and
p65 nuclear translocation by the tanshinone IIA after 48 h was analyzed using western blot analysis in the nuclear and whole cell lysates.
The expressed data are the mean ± standard deviation of three independent experiments, performed in triplicate. Where *P< 0.05 and
**P< 0.01, data were compared with the control group.
Role of Tanshinone IIA in cancer cells 55. Conclusion
In summary, tanshinone II inhibits the migration and invasion
potential of NPC cells and decreases the expression of MMP-2
and MMP-9 through down-regulation of the NF-jB pathway.
Thus tanshinone II can play an important role in the treatment
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